ORGS Stock UPDATES Orgenesis Inc (ORGS) 0.6300 08/21/2014 13

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Orgenesis Inc (ORGS) 0.6300 $ORGS

Scott Carmer Named as CEO of Orgenesis North America
Marketwire - Mon Aug 04, 8:03AM CDT
Orgenesis Inc. (OTCQB: ORGS), a leader in the emerging fields of cellular therapy and re-generative medicine, today announced the appointment of industry veteran Scott Carmer as CEO of the company's North American subsidiary. Carmer has more than 25 years of diverse industry experience within both pharmaceutical and biotech companies.

Orgenesis Signs Agreement With MaSTherCell to Scale Manufacturing of Insulin-Producing Liver Cells to Combat Diabetes
Marketwire - Mon Jul 07, 7:40AM CDT
Orgenesis Inc. (OTCQB: ORGS), a leader in the emerging fields of cellular therapy and re-generative medicine today announced that its Belgian subsidiary, Orgenesis SPRL, has signed a strategic agreement with MaSTherCell SA of Gosselies, Belgium. Orgenesis believes that the agreement will enable Orgenesis to advance its manufacturing (GMP) process from lab scale to clinical scale as it prepares for Phase I and Phase II clinical trials.

Orgenesis Receives $1.5 Million Term Loan to Help Fund Breakthrough Innovation in Diabetes Research
Marketwire - Wed Jun 25, 7:31AM CDT
Orgenesis Inc. (OTCQB: ORGS), a leader in the emerging fields of cellular therapy and re-generative medicine, announced today that it raised $1.5 million via a senior secured term loan facility.

Orgenesis Secures $3 Million in Funding From Kodiak Capital Group
Marketwire - Wed Dec 18, 10:02AM CST
Orgenesis, Inc. (OTCQB: ORGS), a development-stage company with a novel regenerative medicine technology that converts a diabetes patient's liver cells into functioning insulin-producing cells, has entered into a $3 million common stock purchase agreement with Kodiak Capital Group LLC, a Newport Beach, Calif.-based institutional investor.

Orgenesis to Present at the 2013 Gateway Conference on September 10
Marketwire - Wed Sep 04, 4:16PM CDT
Orgenesis, Inc. (OTCBB: ORGS), a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells into functioning insulin-producing cells as a treatment for diabetes, has been invited to present at the 2013 Gateway Conference being held on Tuesday, September 10, 2013 at the Palace Hotel in San Francisco.

Dr. David Sidransky Appointed to Orgenesis' Board of Directors
GlobeNewswire - Thu Jul 18, 1:00PM CDT
Orgenesis Inc. (OTCBB:ORGS) ("Orgenesis" or the "Company" , a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells into functioning insulin-producing cells as a treatment for diabetes, is pleased to announce the appointment of Dr. David Sidransky, Professor and Director of the Head and Neck Cancer Research Division at the Johns Hopkins University School of Medicine's Department of Otolaryngology, to its Board of Directors.

Orgenesis to Present Updates at Two Key June Conferences
GlobeNewswire - Thu May 30, 1:30PM CDT
Orgenesis Inc. (OTCBB:ORGS) ("Orgenesis" or the "Company" , a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells into functioning insulin-producing cells as a treatment for diabetes, is pleased to announce that it will be presenting updates on the Company's business and technology at two key conferences in the month of June.

Orgenesis and ATMI Enter Into Process Development Agreement
GlobeNewswire - Thu May 09, 6:55AM CDT
Orgenesis Inc. (OTCBB:ORGS) ("Orgenesis" or the "Company" , a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells into functioning insulin-producing cells as a treatment for diabetes, announced today that its wholly owned subsidiary, Orgenesis Ltd., has entered into a process development agreement (the "PD Agreement" with ATMI, Inc. (Nasdaq:ATMI), a global technology company and leader in single-use bioprocess solutions.

Leading Diabetes Expert, Jay S. Skyler, M.D., Joins Orgenesis' Scientific Advisory Board
GlobeNewswire - Thu Apr 11, 7:15AM CDT
Orgenesis Inc. (OTCBB:ORGS) ("Orgenesis" or the "Company" , a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells into functioning insulin-producing cells as a treatment for diabetes, is pleased to announce the appointment of Jay S. Skyler, M.D., to its Scientific Advisory Board.

Orgenesis to Present at ATTD 2013
GlobeNewswire - Wed Feb 20, 1:11PM CST
Orgenesis Inc. (OTCBB:ORGS) ("Orgenesis" or the "Company" , a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells into functioning insulin-producing cells as a treatment for diabetes, is pleased to announce that its Chief Science Officer, Prof. Sarah Ferber, is scheduled to present at the 6 International Conference on Advanced Technologies & Treatments for Diabetes, to be held February 27 - March 3, 2013 in Paris, France.

Orgenesis Announces Management Changes
GlobeNewswire - Mon Jan 07, 7:00AM CST
Orgenesis Inc. (OTCBB:ORGS) ("Orgenesis" or the "Company" , a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells into functioning insulin-producing cells as a treatment for diabetes, announced today the appointment of Sav DiPasquale as President and Chief Executive Officer. Mr. DiPasquale succeeds Jacob BenArie, who has been appointed Chief Executive Officer of the Company's private subsidiary, Orgenesis Ltd.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 305

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 266

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 415

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 43

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 279

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 85

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 19

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 294

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 164

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading

Top 5 Most Recently Viewed Articles

The Booming Ethylene Vinyl Acetate Market: Insights and Trends

Updated Category News Views 114

Understanding the Growth of the Ethylene Vinyl Acetate Market As we delve into the dynamic landscape of the Ethylene Vinyl Acetate (EVA) market, it's clear that the demand for sustainable solutions is reshaping this sector. Recently valued at USD 11.0 billion, the market is projected to reach an impressive USD 19.2 billion by 2032, reflecting a compound annual growth rate...

Continue Reading
FETV Lassoing Nostalgia with 'Rawhide' Marathon

Updated Category News Views 35

FETV Brings 'Rawhide' Back for a July 4th Ride If anybody still had doubts about classic TV riding back into our living rooms and kicking up dust, FETV's got a surprise for them. This Independence Day, FETV's all geared up to bring the legendary western series, Rawhide, galloping back onto our screens. A weekend full of cattle drives and cowboy grit is exactly the kind of...

Continue Reading
China-Pakistani Lab Aims to Tackle Earthquake Disasters

Updated Category News Views 29

When the ground decides to play havoc, it takes a teamwork of the ages to put things back together. The China-Pakistan Belt and Road Joint Laboratory on Smart Disaster Prevention has taken on the task of preventing such chaos, especially for regions that flirt regularly with disaster, like Pakistan. From Surviving to Saving The memory of the 7.8-magnitude quake that...

Continue Reading
Investors Alert: Charter Communications Faces Legal Scrutiny

Updated Category News Views 149

Legal Concerns Surrounding Charter Communications Shamis & Gentile, P.A. has initiated an investigation into possible claims on behalf of investors of Charter Communications, Inc. (CHTR). This inquiry aims to assist those who may have suffered losses due to the actions of the company and its executives. Understanding the Investigation Investors in Charter Communications...

Continue Reading
Bumble's Options Activity: Insights and Market Trends

Updated Category News Views 336

Understanding Bumble's Recent Options Activity Recent analyses indicate that substantial financial entities are making bold moves in the options market surrounding Bumble Inc (NASDAQ: BMBL). A deep dive into options trading patterns reveals noteworthy insights about trader sentiment and market expectations. Analyzing Trader Sentiment The current options trades showcase a...

Continue Reading